Astrana Health Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Astrana Health ha aumentado sus beneficios a una tasa media anual de 28.2%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 7.1% anual. Los ingresos han ido creciendo a una tasa media de 22% al año. La rentabilidad financiera de Astrana Health es de 14.1%, y sus márgenes netos son de 4.4%.

Información clave

28.2%

Tasa de crecimiento de los beneficios

23.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	22.0%
Rentabilidad financiera	14.1%
Margen neto	4.4%
Próxima actualización de resultados	07 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16

Apollo Medical to acquire Valley Oaks Medical Group

Oct 05

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

Sep 26

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Sep 21

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

Sep 06

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Aug 22

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Aug 04

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Aug 04

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 17

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Manage Its Debt With Ease

May 02

Do Apollo Medical Holdings's (NASDAQ:AMEH) Earnings Warrant Your Attention?

Apr 17

Apollo Medical: A Novel HealthTech Company Leading The Digital Revolution

Mar 22

Apollo Medical Holdings (NASDAQ:AMEH) Is Doing The Right Things To Multiply Its Share Price

Feb 09

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Astrana Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqCM:ASTH Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	1,387	61	113
30 Sep 23	1,328	45	99
30 Jun 23	1,297	46	91
31 Mar 23	1,218	45	87
31 Dec 22	1,144	45	78
30 Sep 22	1,045	58	67
30 Jun 22	955	69	68
31 Mar 22	861	70	62
31 Dec 21	774	69	62
30 Sep 21	756	70	55
30 Jun 21	709	53	49
31 Mar 21	698	47	47
31 Dec 20	687	38	49
30 Sep 20	689	35	51
30 Jun 20	665	22	43
31 Mar 20	630	18	41
31 Dec 19	561	14	40
30 Sep 19	488	4	44
30 Jun 19	499	10	45
31 Mar 19	492	9	46
31 Dec 18	520	11	47
30 Sep 18	506	28	42
30 Jun 18	436	24	38
31 Mar 18	395	24	33
31 Dec 17	356	26	26
30 Sep 17	336	13	22
30 Jun 17	323	11	23
31 Mar 17	317	12	22
31 Dec 16	306	11	21
31 Dec 15	313	13	27
31 Dec 14	134	-1	36

Ingresos de calidad: ASTH tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (4.4%) de ASTH son superiores a los del año pasado (3.9%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lASTH han crecido significativamente en un 28.2% al año.

Acelerando crecimiento: El crecimiento de los beneficios de ASTH en el último año (34.4%) supera su media de 5 años (28.2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de ASTH en el último año (34.4%) superó al de la industria Healthcare 7.3%.

Astrana Health Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

Astrana Health, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Apollo Medical Holdings, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations

Apollo Medical Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Recent updates

Astrana Health, Inc. to Report Q1, 2024 Results on May 07, 2024

Astrana Health, Inc., Annual General Meeting, Jun 12, 2024

Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

New minor risk - Shareholder dilution

Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Apollo Medical Holdings, Inc. Announces Management Changes

Apollo Medical Holdings: Good Company, Not Quite A Hold

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings: EPS exceeds analyst expectations

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $100 million worth of its shares.

Apollo Medical Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Now 20% undervalued

Apollo Medical Holdings, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Apollo Medical Holdings, Inc. to Report Q2, 2023 Results on Aug 07, 2023

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire Assets of Texas Independent Providers, LLC.

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Medical Holdings, Inc. Provides Earnings Guidance for the Year 2023

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Investor sentiment improves as stock rises 16%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apollo Medical Holdings, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Apollo Medical Holdings, Inc. Announces Resignation of Michael Eng as Board of Directors, Effective February 15, 2023

Investor sentiment improved over the past week

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $50 million worth of its shares.

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $50 million worth of its shares.

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

President exercised options to buy US$2.9m worth of stock.

Apollo Medical Holdings, Inc. Appoints John Vong as Chief Accounting Officer

Chief Administrative Officer exercised options to buy US$1.6m worth of stock.

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Apollo Medical Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Apollo Medical Holdings, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Investor sentiment deteriorated over the past week

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire Valley Oaks Medical Group.

Apollo Medical to acquire Valley Oaks Medical Group

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire All American Medical Group / For Your Benefit, Inc.

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) agreed to acquire 100% of All American Medical Group/For Your Benefit, Inc./as well as certain related managed care assets.

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Apollo Medical Holdings, Inc. Reiterates Earnings Guidance for the Year 2022

Second quarter 2022 earnings released: EPS: US$0.25 (vs US$0.29 in 2Q 2021)

Now 21% undervalued

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Investor sentiment improved over the past week

Apollo Medical Holdings, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Investor sentiment improved over the past week

Apollo Medical Holdings, Inc.(NasdaqCM:AMEH) dropped from Russell Microcap Index

Investor sentiment improved over the past week

Desglose de ingresos y gastos
Beta